Exsilio Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 25, 2024
- Vertical
- Genomic Medicines
- Funding URL
- View Funding Page
- Funding Amount:
- $82,000,000
Company Info
- Founders
- Tal Zaks, M.D., Ph.D.
- Company Description
- Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
- Market
- Genetic Diseases, Cancer, Autoimmune Conditions
- Location
- New York, NY, USA
- Coinvestors
- Arc Ventures, Deep Insight, Delos Capital, Innovation Endeavors, Insight Partners, Invus, Novartis Venture Funds, OrbiMed US